1. Wang, Yuan, Zheng, Fushuang, Wang, Zibo, Lu, Jibin, Zhang, Hongyan. 2020. Circular RNA circ-SLC7A6 acts as a tumor suppressor in non-small cell lung cancer through abundantly sponging miR-21. In Cell cycle (Georgetown, Tex.), 19, 2235-2246. doi:10.1080/15384101.2020.1806449. https://pubmed.ncbi.nlm.nih.gov/32794418/
2. Xia, Pu, Dubrovska, Anna. 2023. CD98 heavy chain as a prognostic biomarker and target for cancer treatment. In Frontiers in oncology, 13, 1251100. doi:10.3389/fonc.2023.1251100. https://pubmed.ncbi.nlm.nih.gov/37823053/
3. Chen, Xiaoxia, Wang, Zhenyu, Zhao, Xinge, Yao, Ming, Li, Jinjun. 2022. STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1. In Oncogene, 41, 2492-2504. doi:10.1038/s41388-022-02273-2. https://pubmed.ncbi.nlm.nih.gov/35314791/
4. Shoji, Yutaka, Noguchi, Atsuko, Shoji, Yasuko, Kitajima, Isao, Takada, Goro. . Five novel SLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance. In Human mutation, 20, 375-81. doi:. https://pubmed.ncbi.nlm.nih.gov/12402335/
5. Tambay, Vincent, Raymond, Valérie-Ann, Voisin, Laure, Meloche, Sylvain, Bilodeau, Marc. 2024. Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma. In International journal of molecular sciences, 25, . doi:10.3390/ijms25147558. https://pubmed.ncbi.nlm.nih.gov/39062801/
6. Sun, Chao, Zeng, Boning, Zhou, Jilong, Wang, Shaoxiang, Wang, Xiao. 2024. Analysis of SLC genes alternative splicing identifies the SLC7A6 RI isoform as a therapeutic target for colorectal cancer. In Cancer science, 116, 233-247. doi:10.1111/cas.16351. https://pubmed.ncbi.nlm.nih.gov/39403788/
7. Lund-Andersen, Christin, Torgunrud, Annette, Kanduri, Chakravarthi, Larsen, Stein G, Flatmark, Kjersti. 2024. Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. In Journal of translational medicine, 22, 646. doi:10.1186/s12967-024-05467-2. https://pubmed.ncbi.nlm.nih.gov/38982444/
8. Huang, Zhigang, Liu, Bin, Li, Xiaoju, Sun, Yimin, Wang, Qian. 2024. RUNX2 enhances bladder cancer progression by promoting glutamine metabolism. In Neoplasia (New York, N.Y.), 60, 101120. doi:10.1016/j.neo.2024.101120. https://pubmed.ncbi.nlm.nih.gov/39733689/
智鼠故事 
